½ÃÀ庸°í¼­
»óǰÄÚµå
1589716

¼¼°èÀÇ ÀüÀÚ ÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ ½Ã½ºÅÛ ½ÃÀå : ÄÄÆ÷³ÍÆ®, À¯Åë, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Electronic Trial Master File Systems Market by Component (Services, Software), Distribution (On-Cloud, On-Premise), End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 184 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀüÀÚ ÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀϽýºÅÛ ½ÃÀåÀº 2023³â 13¾ï 3,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 14¾ï 7,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 9.79%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 25¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀüÀÚÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ(eTMF) ½Ã½ºÅÛÀº ÀÓ»ó½ÃÇè¿¡ ÇʼöÀûÀÎ ¹®¼­¸¦ °ü¸®ÇÏ°í º¸°üÇÏ°í ±ÔÁ¦ ¿ä±¸ »çÇ׿¡ ´ëÇÑ Áؼö¸¦ º¸ÀåÇϱâÀ§ÇÑ µðÁöÅÐ ¼Ö·ç¼ÇÀÔ´Ï´Ù., °¨»ç Áغñ °³¼±, ¿öÅ© Ç÷οìÀÇ ÇÕ¸®È­¿¡ ±âÀÎÇÕ´Ï´Ù. Å×Å©³î·ÎÁö, ÀÇ·á ¿¬±¸ ºÐ¾ß¿¡¼­ ¸Å¿ì Áß¿äÇϸç, ½ºÆù¼­, °³¹ß ¾÷¹« ¼öŹ ±â°ü, ±ÔÁ¦ ´ç±¹ °£ÀÇ È¿°úÀûÀÎ ¿¬°è¸¦ ÃËÁøÇÕ´Ï´Ù. µðÁöÅÐ ¼Ö·ç¼ÇÀÇ Ã¤¿ë È®´ë¿Í ÀÓ»ó½ÃÇè Ȱµ¿ÀÇ È°¼ºÈ­°¡ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â Ŭ¶ó¿ìµå ±â¼úÀÇ Áøº¸, Ç¥ÁØÈ­µÈ ¹®¼­ °ü¸®ÀÇ Çʿ伺, µðÁöÅÐ ÄÄÇöóÀ̾𽺸¦ ÃßÁøÇÏ´Â ±ÔÁ¦ ´ç±¹ÀÇ ¾Ð·Â µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ±âȸ¸¦ Æ÷ÂøÇϱâ À§ÇÑ ±ÇÀå»çÇ×À¸·Î´Â AI ÁÖµµ ºÐ¼® µµ±¸¿¡ ´ëÇÑ ÅõÀÚ, µ¥ÀÌÅÍ º¸¾È °­È­, ¿ø°Ý ±Ù¹« ¿ä±¸¸¦ ÃæÁ·Çϱâ À§ÇÑ Çù¾÷ ±â´ÉÀÇ È®Àå µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª °í¾×ÀÇ µµÀÔ ºñ¿ë, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á, ÀÌ·¯ÇÑ ½Ã½ºÅÛÀ» °ü¸®ÇÏ´Â ¼÷·ÃµÈ Àü¹®°¡ÀÇ Çʿ伺 µîÀÇ °úÁ¦°¡ ¼ºÀåÀ» ¹æÇØÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Áö¿ª¿¡ µû¶ó ±ÔÁ¦ ¿ä°ÇÀÌ ´Ù¸£±â ¶§¹®¿¡ ÄÄÇöóÀ̾𽺠³ë·ÂÀÌ º¹ÀâÇØÁú ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °úÁ¦¸¦ ±Øº¹Çϱâ À§ÇØ ÀÌÇØ°ü°èÀÚ´Â »ç¿ëÀÚ °æÇèÀ» °³¼±Çϱâ À§ÇÑ »ç¿ëÀÚ ÀÎÅÍÆäÀ̽º ¼³°è °³¼±, ´Ù¾çÇÑ ½ÃÇè ±Ô¸ð¿¡ ´ëÀÀÇÏ´Â È®Àå °¡´ÉÇÑ ¼Ö·ç¼Ç °³¹ß, µ¥ÀÌÅÍ ¹«°á¼º°ú Åõ¸í¼ºÀ» ³ôÀ̱â À§ÇØ ºí·ÏüÀÎ ±â¼ú µµÀÔ µî Çõ½Å ºÐ¾ß¿¡ ÁÖ·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. eTMF ½ÃÀåÀÇ Æ¯¼ºÀº ¿ªµ¿ÀûÀÌ°í ºü¸£°Ô ÁøÈ­Çϰí ÀÖÀ¸¸ç, º¸´Ù ÅëÇÕµÈ »óÈ£ ¿î¿ë°¡´ÉÇÑ ½Ã½ºÅÛÀ¸·Î ÇâÇϰí ÀÖ½À´Ï´Ù. ±â¾÷Àº µ¥ÀÌÅÍ ¹«°á¼º°ú ±ÔÁ¦ Áؼö¸¦ º¸ÀåÇϸ鼭 »õ·Î¿î ÀÓ»ó½ÃÇè ¿ä±¸¿¡ ¸ÂÃß¾î ÁøÈ­ÇÒ ¼ö ÀÖ´Â À¯¿¬Çϰí ÀûÀÀ·Â ÀÖ´Â eTMF Ç÷§Æû ±¸Ãà¿¡ ÁÖ·ÂÇØ¾ß ÇÕ´Ï´Ù. Àü¹ÝÀûÀ¸·Î eTMF ½Ã½ºÅÛÀ» Ȱ¿ëÇÏ¿© ÀÓ»ó½ÃÇè °ü¸®¸¦ ÃÖÀûÈ­Çϱâ À§Çؼ­´Â ±â¼úÀÇ Áøº¸¿Í ±ÔÁ¦ º¯È­¸¦ Áö¼ÓÀûÀ¸·Î À¯ÁöÇÏ´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 13¾ï 3,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 14¾ï 7,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 25¾ï 7,000¸¸ ´Þ·¯
CAGR(%) 9.79%

½ÃÀå ¿ªÇÐ: ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â ÀüÀÚ ÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÀüÀÚ ÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ ½Ã½ºÅÛ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû °áÁ¤ Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ëÀ̳ª ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¼¼°èÀÇ ÀÓ»ó½ÃÇè¼ö Áõ°¡¿¡ ±âÀÎÇÏ´Â eTMFÀÇ ÀáÀç ¼ö¿ä
    • â¾àÀ̳ª ÀǾàǰ °³¹ß¿¡ ¼ö¹ÝÇÏ´Â Á¦¾à ºÐ¾ßÀÇ Áö¼ÓÀûÀÎ È®´ë
    • ÇコÄÉ¾î ºÐ¾ßÀÇ µðÁöÅÐÈ­¸¦ ÇâÇÑ Á¤ºÎÀÇ ´ëó¿Í µ¥ÀÌÅÍ °ü¸®¡¤º¸Á¸ÀÇ ¿ä±¸ÀÇ °íÁ¶
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • eTMF ½Ã½ºÅÛÀÇ ¼³Ä¡ ¹× °ü¸®¿¡ µû¸¥ °íºñ¿ë
  • ½ÃÀå ±âȸ
    • ÀüÀÚ ÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ ½Ã½ºÅÛ¿¡¼­ ÷´Ü ±â¼úÀÇ ÅëÇÕ
    • eTMF ½Ã½ºÅÛÀÇ ÅëÇÕ ¼Ö·ç¼Ç Çõ½ÅÀ» À§ÇÑ À¯¸®ÇÑ ÅõÀÚ È¯°æ
  • ½ÃÀåÀÇ °úÁ¦
    • ÀÇ·á µ¥ÀÌÅÍÀÇ ÇÁ¶óÀ̹ö½Ã¿Í ¾Ç¿ë¿¡ °üÇÑ ¿ì·Á

Porter's Five Forces: ÀüÀÚ ÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ ½Ã½ºÅÛ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÆÄ¾ÇÇϱâ À§ÇÑ Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ´ç½ÅÀº ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÀüÀÚ ÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ ½Ã½ºÅÛ ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÀüÀÚ ÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ ½Ã½ºÅÛ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸ À» Á¦°øÇÕ´Ï´Ù.PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×¸®°í ¾ÕÀ» ³»´Ùº¸°í Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ µË´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ÀüÀÚ ÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ ½Ã½ºÅÛ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

ÀüÀÚ ÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ ½Ã½ºÅÛ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. Æ÷Áö¼Å´× À̸¦ ÅëÇØ ½ÃÀåÀÇ ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í, º¥´õ´Â °æÀïÀÌ °ÝÈ­ÇÏ´Â °¡¿îµ¥ ÀÚ½ÅÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» Çϱâ À§Çؼ­ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ÀüÀÚ ÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ ½Ã½ºÅÛ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÀüÀÚ ÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ ½Ã½ºÅÛ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå : ÀüÀÚ ÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ ½Ã½ºÅÛ ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ °æ·Î¸¦ ±×¸®±â

ÀüÀÚ ÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀϽýºÅÛ ½ÃÀåÀÇ Àü·«ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° ½ÃÀå, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¼¼°è¿¡¼­ ÀÓ»ó½ÃÇè¼ö°¡ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ eTMFÀÇ ÀáÀçÀû ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ´Ù
      • ÀǾàǰ ºÐ¾ßÀÇ Áö¼ÓÀûÀÎ È®´ë¿Í ½Å¾àÀÇ ¹ß°ß ¹× °³¹ß
      • ÇコÄÉ¾î ºÐ¾ßÀÇ µðÁöÅÐÈ­¸¦ À§ÇÑ Á¤ºÎÀÇ ´ëó¿Í, µ¥ÀÌÅÍ °ü¸® ¹× º¸°üÀÇ Çʿ伺 Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • eTMF ½Ã½ºÅÛ ¼³Ä¡ ¹× °ü¸®¿Í °ü·ÃµÈ ³ôÀº ºñ¿ë
    • ±âȸ
      • ÀüÀÚ ÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ ½Ã½ºÅÛ¿¡¼­ ÷´Ü ±â¼úÀÇ ÅëÇÕ
      • eTMF ½Ã½ºÅÛÀ» À§ÇÑ ÅëÇÕ ¼Ö·ç¼Ç Çõ½ÅÀ» À§ÇÑ ¼±È£ÇÏ´Â ÅõÀÚ »óȲ
    • °úÁ¦
      • ÀÇ·á µ¥ÀÌÅÍÀÇ ÇÁ¶óÀ̹ö½Ã¿Í ¾Ç¿ë¿¡ °üÇÑ ¿ì·Á
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ÀüÀÚÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ ½Ã½ºÅÛ ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

  • ¼­ºñ½º
  • ¼ÒÇÁÆ®¿þ¾î

Á¦7Àå ÀüÀÚÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ ½Ã½ºÅÛ ½ÃÀå : ¹èÆ÷º°

  • Ŭ¶ó¿ìµå»ó
  • ¿ÂÇÁ·¹¹Ì½º

Á¦8Àå ÀüÀÚÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • °è¾à¿¬±¸±â°ü
  • Á¦¾à ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ÀüÀÚÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀϽýºÅÛ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀüÀÚ ÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ ½Ã½ºÅÛ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀüÀÚÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ ½Ã½ºÅÛ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • Çѱ¹ ÃÖ´ë CROÀÎ C&R Research´Â ÀÓ»ó ¾÷¹«¸¦ °­È­Çϱâ À§ÇØ Medidata¿ÍÀÇ Á¦ÈÞ¸¦ È®´ëÇß½À´Ï´Ù.
    • Anju´Â ÀÓ»ó½ÃÇè¿¡¼­ ÀüÀÚ ½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ °ü¸®¸¦ À§ÇÑ eTMF Master¸¦ µµÀÔÇß½À´Ï´Ù.
    • ArisGlobal, APAC ¹× Áßµ¿¿¡¼­ ȹ±âÀûÀÎ °í°´ ȹµæÀ» ÅëÇØ LifeSphere Clinical Æ÷Æ®Æú¸®¿À È®´ë
    • TriallÀº Crucial Data Solutions¿Í Á¦ÈÞÇϰí ÀÖ½À´Ï´Ù.
    • PharmaLex GroupÀº Phhlexglobal°úÀÇ ÇÕº´À» ¹ßÇ¥Çß½À´Ï´Ù.
    • CARMATÀº ÀÓ»ó½ÃÇèÀÇ ¹®¼­È­¿Í ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­Çϱâ À§ÇØ Veeva Vault eTMF¸¦ ¼±ÅÃÇß½À´Ï´Ù.
    • Medrio, Inc.¿Í PharmasealÀº Á¦ÈÞÇÏ¿© ÀÓ»ó ¿¬±¸¸¦ À§ÇÑ °£¼ÒÈ­µÈ Á¾´Ü °£ µ¥ÀÌÅÍ ¼öÁý ¹× °ü¸®¸¦ Á¦°øÇÕ´Ï´Ù.
    • Cloudbyz´Â ºÐ»ê ÀÓ»ó½ÃÇèÀ» À§ÇÑ »õ·Î¿î ¼Ö·ç¼ÇÀ» µµÀÔÇÕ´Ï´Ù.
    • Alimentiv´Â eTMF ¼Ö·ç¼ÇÀ» µµÀÔÇϱâ À§ÇØ Veeva Vault¸¦ ¼±ÅÃÇß½À´Ï´Ù.
    • ArisGlobal LifeSphere eTMF´Â »õ·Î¿î ÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ Ç¥ÁØÀ» Áö¿øÇÏ¿© ÀÓ»ó Á¶»ç¿¡¼­ Çù¾÷À» ÃËÁøÇÕ´Ï´Ù.
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Advarra, Inc.
  • Anju Software, Inc.
  • ArborSys Group
  • ArisGlobal LLC
  • Aurea, Inc.
  • Cereblis LLC
  • Clario by eResearchTechnology GmbH
  • Clinblocks BV
  • Clinevo Technologies Private Limited
  • Cloudbyz, Inc.
  • ComplianceQuest
  • Crucial Data Solutions, Inc.
  • Daffodil Software Private Limited
  • Dassault Systemes
  • DataRiver Srl
  • Dell Technologies, Inc.
  • Ennov SAS
  • ethica CRO Inc.
  • EvidentIQ Group GmbH
  • Flex Databases sro
  • Florence Healthcare, Inc.
  • Freyr Solutions
  • ICON PLC
  • IKCON PHARMA Inc.
  • IQVIA Inc.
  • Kivo, Inc.
  • Laboratory Corporation of America Holdings
  • MasterControl Solutions, Inc.
  • McDougall Scientific Ltd.
  • Medrio, Inc.
  • Montrium Inc.
  • Navitas Life Sciences
  • Novotech Health Holdings
  • Octalsoft
  • OpenClinica, LLC
  • Oracle Corporation
  • PHARMASEAL
  • Phlexglobal Ltd. by PharmaLex Group
  • Prevail Infoworks, Inc.
  • Questex LLC
  • Sarjen Systems Pvt. Ltd.
  • SGS Societe Generale de Surveillance SA
  • SimpleTrials
  • SMART-TRIAL ApS
  • SureClinical Inc.
  • TCell Clinical Services
  • Techsol Corporation
  • TransPerfect Translations GmbH
  • Veeva Systems Inc.
  • Vial Health Technology, Inc.
JHS 24.11.21

The Electronic Trial Master File Systems Market was valued at USD 1.33 billion in 2023, expected to reach USD 1.47 billion in 2024, and is projected to grow at a CAGR of 9.79%, to USD 2.57 billion by 2030.

An Electronic Trial Master File (eTMF) system is a digital solution for managing and storing essential clinical trial documents, ensuring compliance with regulatory requirements. The necessity of eTMF systems stems from their ability to enhance operational efficiency, improve audit readiness, and streamline workflows in clinical trials. They are crucial in pharmaceutical, biotechnology, and medical research sectors, facilitating effective collaboration among sponsors, contract research organizations, and regulatory bodies. The growing adoption of digital solutions and increasing clinical trial activities are driving market growth. Key growth factors include advancements in cloud technology, the need for standardized document management, and regulatory pressures driving digital compliance. The latest potential opportunities lie in the integration of advanced analytics and AI for predictive insights, enhancing decision-making processes within eTMFs. Recommendations for capturing these opportunities include investing in AI-driven analytics tools, emphasizing data security enhancements, and expanding collaborative features to meet remote working needs. However, challenges such as high implementation costs, data privacy concerns, and the need for skilled professionals to manage these systems can impede growth. Furthermore, varying regulatory requirements across regions may complicate compliance efforts. To overcome these challenges, stakeholders can focus on areas of innovation like improving user interface design for enhanced user experience, developing scalable solutions for varying trial sizes, and incorporating blockchain technology for data integrity and transparency. The nature of the eTMF market is dynamic and rapidly evolving, with a trend toward more integrated and interoperable systems. Companies should focus on creating flexible and adaptive eTMF platforms capable of evolving with emerging trial needs while ensuring data integrity and regulatory compliance. Overall, staying attuned to technological advancements and regulatory changes will be crucial in leveraging eTMF systems for optimized clinical trial management.

KEY MARKET STATISTICS
Base Year [2023] USD 1.33 billion
Estimated Year [2024] USD 1.47 billion
Forecast Year [2030] USD 2.57 billion
CAGR (%) 9.79%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Electronic Trial Master File Systems Market

The Electronic Trial Master File Systems Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Potential demand for eTMF attributed to increasing numbers of clinical trials worldwide
    • Ongoing expansion of pharmaceutical sectors coupled with drug discovery and drug developments
    • Government initiatives for digitalization of healthcare sector coupled with growing need for data management and storage
  • Market Restraints
    • High cost associated with installations and management of eTMF systems
  • Market Opportunities
    • Integration of advanced technologies in electronic trial master file systems
    • Favorable investment landscape to innovate integrated solutions for eTMF systems
  • Market Challenges
    • Concern regarding the medical data privacy and misuse

Porter's Five Forces: A Strategic Tool for Navigating the Electronic Trial Master File Systems Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Electronic Trial Master File Systems Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Electronic Trial Master File Systems Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Electronic Trial Master File Systems Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Electronic Trial Master File Systems Market

A detailed market share analysis in the Electronic Trial Master File Systems Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Electronic Trial Master File Systems Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Electronic Trial Master File Systems Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Electronic Trial Master File Systems Market

A strategic analysis of the Electronic Trial Master File Systems Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Electronic Trial Master File Systems Market, highlighting leading vendors and their innovative profiles. These include Advarra, Inc., Anju Software, Inc., ArborSys Group, ArisGlobal LLC, Aurea, Inc., Cereblis LLC, Clario by eResearchTechnology GmbH, Clinblocks B.V., Clinevo Technologies Private Limited, Cloudbyz, Inc., ComplianceQuest, Crucial Data Solutions, Inc., Daffodil Software Private Limited, Dassault Systemes, DataRiver S.r.l., Dell Technologies, Inc., Ennov SAS, ethica CRO Inc., EvidentIQ Group GmbH, Flex Databases s.r.o., Florence Healthcare, Inc., Freyr Solutions, ICON PLC, IKCON PHARMA Inc., IQVIA Inc., Kivo, Inc., Laboratory Corporation of America Holdings, MasterControl Solutions, Inc., McDougall Scientific Ltd., Medrio, Inc., Montrium Inc., Navitas Life Sciences, Novotech Health Holdings, Octalsoft, OpenClinica, LLC, Oracle Corporation, PHARMASEAL, Phlexglobal Ltd. by PharmaLex Group, Prevail Infoworks, Inc., Questex LLC, Sarjen Systems Pvt. Ltd., SGS Societe Generale de Surveillance SA, SimpleTrials, SMART-TRIAL ApS, SureClinical Inc., TCell Clinical Services, Techsol Corporation, TransPerfect Translations GmbH, Veeva Systems Inc., and Vial Health Technology, Inc..

Market Segmentation & Coverage

This research report categorizes the Electronic Trial Master File Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Component, market is studied across Services and Software.
  • Based on Distribution, market is studied across On-Cloud and On-Premise.
  • Based on End-User, market is studied across Contract Research Organizations and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Potential demand for eTMF attributed to increasing numbers of clinical trials worldwide
      • 5.1.1.2. Ongoing expansion of pharmaceutical sectors coupled with drug discovery and drug developments
      • 5.1.1.3. Government initiatives for digitalization of healthcare sector coupled with growing need for data management and storage
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with installations and management of eTMF systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of advanced technologies in electronic trial master file systems
      • 5.1.3.2. Favorable investment landscape to innovate integrated solutions for eTMF systems
    • 5.1.4. Challenges
      • 5.1.4.1. Concern regarding the medical data privacy and misuse
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Electronic Trial Master File Systems Market, by Component

  • 6.1. Introduction
  • 6.2. Services
  • 6.3. Software

7. Electronic Trial Master File Systems Market, by Distribution

  • 7.1. Introduction
  • 7.2. On-Cloud
  • 7.3. On-Premise

8. Electronic Trial Master File Systems Market, by End-User

  • 8.1. Introduction
  • 8.2. Contract Research Organizations
  • 8.3. Pharmaceutical & Biotechnology Companies

9. Americas Electronic Trial Master File Systems Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Electronic Trial Master File Systems Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Electronic Trial Master File Systems Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. C&R Research, the Largest Korean CRO, Expands Partnership with Medidata to Enhance Their Clinical Operations.
    • 12.3.2. Anju Introduces eTMF Master for Electronic Trial Master File Management in Clinical Studies.
    • 12.3.3. ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East.
    • 12.3.4. Triall partners with Crucial Data Solutions.
    • 12.3.5. PharmaLex Group has announced a merger with Phlexglobal.
    • 12.3.6. CARMAT Selects Veeva Vault eTMF to Streamline Clinical Trial Documentation and Processes.
    • 12.3.7. Medrio, Inc. and Pharmaseal unite to Offer Streamlined End-to-End Data Collection and Management for Clinical Studies.
    • 12.3.8. Cloudbyz introduces new solutions for decentralised clinical trials.
    • 12.3.9. Alimentiv Selects Veeva Vault to Launch eTMF Solution.
    • 12.3.10. ArisGlobal LifeSphere eTMF boosts collaboration in clinical research by supporting new Trial Master File Standard.
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advarra, Inc.
  • 2. Anju Software, Inc.
  • 3. ArborSys Group
  • 4. ArisGlobal LLC
  • 5. Aurea, Inc.
  • 6. Cereblis LLC
  • 7. Clario by eResearchTechnology GmbH
  • 8. Clinblocks B.V.
  • 9. Clinevo Technologies Private Limited
  • 10. Cloudbyz, Inc.
  • 11. ComplianceQuest
  • 12. Crucial Data Solutions, Inc.
  • 13. Daffodil Software Private Limited
  • 14. Dassault Systemes
  • 15. DataRiver S.r.l.
  • 16. Dell Technologies, Inc.
  • 17. Ennov SAS
  • 18. ethica CRO Inc.
  • 19. EvidentIQ Group GmbH
  • 20. Flex Databases s.r.o.
  • 21. Florence Healthcare, Inc.
  • 22. Freyr Solutions
  • 23. ICON PLC
  • 24. IKCON PHARMA Inc.
  • 25. IQVIA Inc.
  • 26. Kivo, Inc.
  • 27. Laboratory Corporation of America Holdings
  • 28. MasterControl Solutions, Inc.
  • 29. McDougall Scientific Ltd.
  • 30. Medrio, Inc.
  • 31. Montrium Inc.
  • 32. Navitas Life Sciences
  • 33. Novotech Health Holdings
  • 34. Octalsoft
  • 35. OpenClinica, LLC
  • 36. Oracle Corporation
  • 37. PHARMASEAL
  • 38. Phlexglobal Ltd. by PharmaLex Group
  • 39. Prevail Infoworks, Inc.
  • 40. Questex LLC
  • 41. Sarjen Systems Pvt. Ltd.
  • 42. SGS Societe Generale de Surveillance SA
  • 43. SimpleTrials
  • 44. SMART-TRIAL ApS
  • 45. SureClinical Inc.
  • 46. TCell Clinical Services
  • 47. Techsol Corporation
  • 48. TransPerfect Translations GmbH
  • 49. Veeva Systems Inc.
  • 50. Vial Health Technology, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦